Shares in Aortech International, the developer of a polymer for medical devices, fell following the announcement that it is in dispute with its largest customer, St Jude Medical.
The dispute centres around the use that St Jude Medical is making of Optim, which is actually Elasteon supplied by Aortech. Aortech alleges that there has been a "material breach of contract" by St Jude Medical.
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
It is the latest blow in a long-running saga that has given investors a white knuckle ride over the past year, during which its share price hit a high of 371p before plummeting.
In late September, Aortech's shares halved after warning that takeover talks had collapsed and that it was investigating funding options.
CM
-
What is the 7 year inheritance tax rule and how does it help cut your bill?Speculation is rife chancellor Rachel Reeves has plans to target inheritance tax once again in her upcoming Budget. But the 7 year inheritance tax rule can save you thousands - here’s how it works.
-
HMRC confirms crypto ETN ISA rulesWith crypto ETNs now technically available for UK retail investors, HMRC has confirmed they can be held in an ISA – but there’s a complication
